Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC [Phase 2]
Phase 2 trial evaluating anlotinib plus pemetrexed in advanced non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 4]
Phase 4 trial update evaluating afatinib as second-line therapy for non-small cell lung cancer with EGFR mutation; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies [NA]
A prospective, multi-center study evaluated the use of a powered vascular stapler during video-assisted thoracoscopic lobectomies for non-sm…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer [Phase 3]
Phase 3 study of abemaciclib in previously treated KRAS-mutated non-small cell lung cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR [Phase 2]
Phase 2 clinical trial update evaluating erlotinib in patients with resected, early-stage non-small cell lung cancer harboring EGFR mutation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating Abraxane maintenance after Abraxane plus carboplatin in first-line stage IIIB/IV squamous cell non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC [Phase 4]
Trial update for anlotinib plus pemetrexed versus pemetrexed for previously untreated elderly or PS 2 non-squamous NSCLC (Phase 4).
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating erlotinib with paclitaxel and carboplatin in stage III/IV or recurrent non-small cell lung cancer has completed wit…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative [Phase 2]
Phase 2 clinical trial evaluating anlotinib plus sintilimab for non-small cell lung cancer in patients with resistance to first-generation E…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating mogamulizumab in combination with docetaxel for non-small cell lung cancer; the study has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial investigating safety and efficacy of high-dose vitamin C infusion with local hyperthermia (mEHT) in various stages of non-sma…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) [Phase 3]
Phase 3 KEYNOTE-189 study evaluating pembrolizumab plus pemetrexed and platinum versus chemotherapy alone in first-line metastatic nonsquamo…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC [Phase 2]
Phase 2 trial evaluating anlotinib plus docetaxel versus docetaxel alone in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-27Clinical Trial Update: Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation [Phase 2]
Phase 2 trial evaluating icotinib with radiation therapy for non-small cell lung cancer with brain metastases and EGFR mutation.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating anlotinib in combination with docetaxel for advanced non-squamous non-small cell lung cancer. Status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating icotinib as neoadjuvant therapy for EGFR-mutant stage IIIA-N2 non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update on Hsp90 inhibitor AUY922 combined with erlotinib in stage IIIB-IV non-small cell lung cancer; study completed with po…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) [Phase 3]
Phase 3 IMpower111 trial comparing atezolizumab to gemcitabine plus cisplatin or carboplatin in PD-L1-selected stage IV squamous non-small c…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） [Phase 2]
A Phase 2 clinical trial updating on Anlotinib combined with Docetaxel for advanced non-small cell lung cancer (ALTER-L034).
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update involving Avastin and Tarceva for locally advanced or metastatic non-squamous non-small cell lung cancer across Phase …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab for malignant pleural effusions in patients with non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing AZD9291 (osimertinib) to gefitinib or erlotinib in locally advanced or metastatic EGFR-sensitizing mutation positive…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating Anlotinib for second-line therapy in elderly patients with EGFR wild-type lung adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC. [Phase 3]
Phase 3 trial comparing dacomitinib to gefitinib in first-line advanced non-small cell lung cancer with EGFR-activating mutations; results p…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 trial evaluating erlotinib in locally advanced or metastatic non-small cell lung cancer with EGFR mutations has completed with resul…